KANWARDEEP AIDEN: Open Payments
NPI 1336109875 · STATEN ISLAND, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$663 in 35 payments from 9 companies in 2025. Trend: 2023 $817 · 2024 $911 · 2025 $663
Food & beverage: $663
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $220 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $181 |
| PFIZER INC. | 4 | $72 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| Phathom Pharmaceuticals, Inc. | 2 | $37 |
| GlaxoSmithKline, LLC. | 2 | $35 |
| ABBVIE INC. | 1 | $26 |
| Exact Sciences Corporation | 1 | $22 |
| Novo Nordisk Inc | 1 | $16 |
Products named: JARDIANCE, FARXIGA, BREZTRI, Kerendia, VOQUEZNA, PAXLOVID, UBRELVY, Cologuard Collection Kit.
Industry payments across NY — which companies pay providers there.
